Physostigmine in the treatment of gamma-hydroxybutyric acid overdose

Mayo Clin Proc. 2000 Apr;75(4):401-2. doi: 10.4065/75.4.401.

Abstract

The widespread abuse of the recreational drug gamma-hydroxybutyric acid has resulted in several reports of overdose leading to coma. The use of a short-acting anticholinesterase agent such as physostigmine as a potential reversal agent has been proposed previously. We report 2 cases of gamma-hydroxybutyric acid-induced coma that rapidly reversed with intravenous administration of physostigmine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cholinesterase Inhibitors / therapeutic use*
  • Drug Overdose / drug therapy
  • Female
  • Humans
  • Hydroxybutyrates / adverse effects*
  • Male
  • Physostigmine / therapeutic use*
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Hydroxybutyrates
  • 4-hydroxybutyric acid
  • Physostigmine